19 research outputs found
(2,2â˛-Biquinoline-Îş2 N,Nâ˛)dichloridoÂiron(II)
In the title compound, [FeCl2(C18H12N2)], the FeII atom is four-coordinated in a distorted tetraÂhedral arrangement by an N,Nâ˛-bidentate 2,2â˛-biquinoline ligand and two chloride ions. In the crystal, there are extensive ĎâĎ contacts between the pyridine rings [centroidâcentroid distances = 3.7611â
(3), 3.7603â
(4), 3.5292â
(4), 3.5336â
(5) and 3.6656â
(4)â
Ă
]
Pedobarography of the coper and non-coper ACL-deficient knee subjects during single and double leg stance
Introduction: Biomechanical studies have frequently shown a close relationship between the knee and ankle joint movements. ACL-deficiency may change the foot pressure pattern of the ACL-deficient knee subjects. The current study aimed to investigate the pattern of the foot pressure in coper and non-coper ACL-deficient knee subjects during standing on one and both feet. Methods and Materials: This case-control study was conducted on 12 coper and 12 non-coper ACL-deficient knee subjects and 25 age-sex matched healthy subjects. The subjects were tested barefoot during single and bilateral standing on the platform of a Zebris pedobarograph tool. The outcome measures included the measurements of the pressures of each part of the foot during the tests. Results: The results showed a significantly decreased total pressure only between the non-coper and control groups during double leg stance test. In terms of the forefoot pressure, a significant increased pressure was shown only in the non-coper ACL-deficient knee subjects during both single and double leg stance tests (P<0.05). In both test conditions, the coper ACL-deficient knee subjects showed forefoot and hind foot pressures very close to the control group (P>0.05). Conclusion: This study revealed marked changes following ACL-deficiency mainlyin non-coper ACL-deficient knee subjects. The increased forefoot pressure in non-coper ACL-deficient knee subjects was probably due to the forwarded line of gravity in these patients aligned with their base of support to keep their knees more stable. Further studies are needed to verify the differences between the male and female ACL-deficient knee subjects.Keywords: Coper/non-coper ACL-deficient knee subjects; Stability; Pedobarograph; Foot pressure system; Postural contro
Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990â2021: a systematic analysis for the Global Burden of Disease Study 2021
Background: Understanding the health consequences associated with exposure to risk factors is necessary to inform public health policy and practice. To systematically quantify the contributions of risk factor exposures to specific health outcomes, the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 aims to provide comprehensive estimates of exposure levels, relative health risks, and attributable burden of disease for 88 risk factors in 204 countries and territories and 811 subnational locations, from 1990 to 2021. Methods: The GBD 2021 risk factor analysis used data from 54 561 total distinct sources to produce epidemiological estimates for 88 risk factors and their associated health outcomes for a total of 631 riskâoutcome pairs. Pairs were included on the basis of data-driven determination of a riskâoutcome association. Age-sex-location-year-specific estimates were generated at global, regional, and national levels. Our approach followed the comparative risk assessment framework predicated on a causal web of hierarchically organised, potentially combinative, modifiable risks. Relative risks (RRs) of a given outcome occurring as a function of risk factor exposure were estimated separately for each riskâoutcome pair, and summary exposure values (SEVs), representing risk-weighted exposure prevalence, and theoretical minimum risk exposure levels (TMRELs) were estimated for each risk factor. These estimates were used to calculate the population attributable fraction (PAF; ie, the proportional change in health risk that would occur if exposure to a risk factor were reduced to the TMREL). The product of PAFs and disease burden associated with a given outcome, measured in disability-adjusted life-years (DALYs), yielded measures of attributable burden (ie, the proportion of total disease burden attributable to a particular risk factor or combination of risk factors). Adjustments for mediation were applied to account for relationships involving risk factors that act indirectly on outcomes via intermediate risks. Attributable burden estimates were stratified by Socio-demographic Index (SDI) quintile and presented as counts, age-standardised rates, and rankings. To complement estimates of RR and attributable burden, newly developed burden of proof risk function (BPRF) methods were applied to yield supplementary, conservative interpretations of riskâoutcome associations based on the consistency of underlying evidence, accounting for unexplained heterogeneity between input data from different studies. Estimates reported represent the mean value across 500 draws from the estimate's distribution, with 95% uncertainty intervals (UIs) calculated as the 2¡5th and 97¡5th percentile values across the draws. Findings: Among the specific risk factors analysed for this study, particulate matter air pollution was the leading contributor to the global disease burden in 2021, contributing 8¡0% (95% UI 6¡7â9¡4) of total DALYs, followed by high systolic blood pressure (SBP; 7¡8% [6¡4â9¡2]), smoking (5¡7% [4¡7â6¡8]), low birthweight and short gestation (5¡6% [4¡8â6¡3]), and high fasting plasma glucose (FPG; 5¡4% [4¡8â6¡0]). For younger demographics (ie, those aged 0â4 years and 5â14 years), risks such as low birthweight and short gestation and unsafe water, sanitation, and handwashing (WaSH) were among the leading risk factors, while for older age groups, metabolic risks such as high SBP, high body-mass index (BMI), high FPG, and high LDL cholesterol had a greater impact. From 2000 to 2021, there was an observable shift in global health challenges, marked by a decline in the number of all-age DALYs broadly attributable to behavioural risks (decrease of 20¡7% [13¡9â27¡7]) and environmental and occupational risks (decrease of 22¡0% [15¡5â28¡8]), coupled with a 49¡4% (42¡3â56¡9) increase in DALYs attributable to metabolic risks, all reflecting ageing populations and changing lifestyles on a global scale. Age-standardised global DALY rates attributable to high BMI and high FPG rose considerably (15¡7% [9¡9â21¡7] for high BMI and 7¡9% [3¡3â12¡9] for high FPG) over this period, with exposure to these risks increasing annually at rates of 1¡8% (1¡6â1¡9) for high BMI and 1¡3% (1¡1â1¡5) for high FPG. By contrast, the global risk-attributable burden and exposure to many other risk factors declined, notably for risks such as child growth failure and unsafe water source, with age-standardised attributable DALYs decreasing by 71¡5% (64¡4â78¡8) for child growth failure and 66¡3% (60¡2â72¡0) for unsafe water source. We separated risk factors into three groups according to trajectory over time: those with a decreasing attributable burden, due largely to declining risk exposure (eg, diet high in trans-fat and household air pollution) but also to proportionally smaller child and youth populations (eg, child and maternal malnutrition); those for which the burden increased moderately in spite of declining risk exposure, due largely to population ageing (eg, smoking); and those for which the burden increased considerably due to both increasing risk exposure and population ageing (eg, ambient particulate matter air pollution, high BMI, high FPG, and high SBP). Interpretation: Substantial progress has been made in reducing the global disease burden attributable to a range of risk factors, particularly those related to maternal and child health, WaSH, and household air pollution. Maintaining efforts to minimise the impact of these risk factors, especially in low SDI locations, is necessary to sustain progress. Successes in moderating the smoking-related burden by reducing risk exposure highlight the need to advance policies that reduce exposure to other leading risk factors such as ambient particulate matter air pollution and high SBP. Troubling increases in high FPG, high BMI, and other risk factors related to obesity and metabolic syndrome indicate an urgent need to identify and implement interventions
Global, regional, and national burden of disorders affecting the nervous system, 1990â2021: a systematic analysis for the Global Burden of Disease Study 2021
BackgroundDisorders affecting the nervous system are diverse and include neurodevelopmental disorders, late-life neurodegeneration, and newly emergent conditions, such as cognitive impairment following COVID-19. Previous publications from the Global Burden of Disease, Injuries, and Risk Factor Study estimated the burden of 15 neurological conditions in 2015 and 2016, but these analyses did not include neurodevelopmental disorders, as defined by the International Classification of Diseases (ICD)-11, or a subset of cases of congenital, neonatal, and infectious conditions that cause neurological damage. Here, we estimate nervous system health loss caused by 37 unique conditions and their associated risk factors globally, regionally, and nationally from 1990 to 2021.MethodsWe estimated mortality, prevalence, years lived with disability (YLDs), years of life lost (YLLs), and disability-adjusted life-years (DALYs), with corresponding 95% uncertainty intervals (UIs), by age and sex in 204 countries and territories, from 1990 to 2021. We included morbidity and deaths due to neurological conditions, for which health loss is directly due to damage to the CNS or peripheral nervous system. We also isolated neurological health loss from conditions for which nervous system morbidity is a consequence, but not the primary feature, including a subset of congenital conditions (ie, chromosomal anomalies and congenital birth defects), neonatal conditions (ie, jaundice, preterm birth, and sepsis), infectious diseases (ie, COVID-19, cystic echinococcosis, malaria, syphilis, and Zika virus disease), and diabetic neuropathy. By conducting a sequela-level analysis of the health outcomes for these conditions, only cases where nervous system damage occurred were included, and YLDs were recalculated to isolate the non-fatal burden directly attributable to nervous system health loss. A comorbidity correction was used to calculate total prevalence of all conditions that affect the nervous system combined.FindingsGlobally, the 37 conditions affecting the nervous system were collectively ranked as the leading group cause of DALYs in 2021 (443 million, 95% UI 378â521), affecting 3¡40 billion (3¡20â3¡62) individuals (43¡1%, 40¡5â45¡9 of the global population); global DALY counts attributed to these conditions increased by 18¡2% (8¡7â26¡7) between 1990 and 2021. Age-standardised rates of deaths per 100â000 people attributed to these conditions decreased from 1990 to 2021 by 33¡6% (27¡6â38¡8), and age-standardised rates of DALYs attributed to these conditions decreased by 27¡0% (21¡5â32¡4). Age-standardised prevalence was almost stable, with a change of 1¡5% (0¡7â2¡4). The ten conditions with the highest age-standardised DALYs in 2021 were stroke, neonatal encephalopathy, migraine, Alzheimer's disease and other dementias, diabetic neuropathy, meningitis, epilepsy, neurological complications due to preterm birth, autism spectrum disorder, and nervous system cancer.InterpretationAs the leading cause of overall disease burden in the world, with increasing global DALY counts, effective prevention, treatment, and rehabilitation strategies for disorders affecting the nervous system are needed
Recommended from our members
Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990â2021: a systematic analysis for the Global Burden of Disease Study 2021
BACKGROUND Regular, detailed reporting on population health by underlying cause of death is fundamental for public health decision making. Cause-specific estimates of mortality and the subsequent effects on life expectancy worldwide are valuable metrics to gauge progress in reducing mortality rates. These estimates are particularly important following large-scale mortality spikes, such as the COVID-19 pandemic. When systematically analysed, mortality rates and life expectancy allow comparisons of the consequences of causes of death globally and over time, providing a nuanced understanding of the effect of these causes on global populations. METHODS The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2021 cause-of-death analysis estimated mortality and years of life lost (YLLs) from 288 causes of death by age-sex-location-year in 204 countries and territories and 811 subnational locations for each year from 1990 until 2021. The analysis used 56â604 data sources, including data from vital registration and verbal autopsy as well as surveys, censuses, surveillance systems, and cancer registries, among others. As with previous GBD rounds, cause-specific death rates for most causes were estimated using the Cause of Death Ensemble model-a modelling tool developed for GBD to assess the out-of-sample predictive validity of different statistical models and covariate permutations and combine those results to produce cause-specific mortality estimates-with alternative strategies adapted to model causes with insufficient data, substantial changes in reporting over the study period, or unusual epidemiology. YLLs were computed as the product of the number of deaths for each cause-age-sex-location-year and the standard life expectancy at each age. As part of the modelling process, uncertainty intervals (UIs) were generated using the 2¡5th and 97¡5th percentiles from a 1000-draw distribution for each metric. We decomposed life expectancy by cause of death, location, and year to show cause-specific effects on life expectancy from 1990 to 2021. We also used the coefficient of variation and the fraction of population affected by 90% of deaths to highlight concentrations of mortality. Findings are reported in counts and age-standardised rates. Methodological improvements for cause-of-death estimates in GBD 2021 include the expansion of under-5-years age group to include four new age groups, enhanced methods to account for stochastic variation of sparse data, and the inclusion of COVID-19 and other pandemic-related mortality-which includes excess mortality associated with the pandemic, excluding COVID-19, lower respiratory infections, measles, malaria, and pertussis. For this analysis, 199 new country-years of vital registration cause-of-death data, 5 country-years of surveillance data, 21 country-years of verbal autopsy data, and 94 country-years of other data types were added to those used in previous GBD rounds. FINDINGS The leading causes of age-standardised deaths globally were the same in 2019 as they were in 1990; in descending order, these were, ischaemic heart disease, stroke, chronic obstructive pulmonary disease, and lower respiratory infections. In 2021, however, COVID-19 replaced stroke as the second-leading age-standardised cause of death, with 94¡0 deaths (95% UI 89¡2-100¡0) per 100â000 population. The COVID-19 pandemic shifted the rankings of the leading five causes, lowering stroke to the third-leading and chronic obstructive pulmonary disease to the fourth-leading position. In 2021, the highest age-standardised death rates from COVID-19 occurred in sub-Saharan Africa (271¡0 deaths [250¡1-290¡7] per 100â000 population) and Latin America and the Caribbean (195¡4 deaths [182¡1-211¡4] per 100â000 population). The lowest age-standardised death rates from COVID-19 were in the high-income super-region (48¡1 deaths [47¡4-48¡8] per 100â000 population) and southeast Asia, east Asia, and Oceania (23¡2 deaths [16¡3-37¡2] per 100â000 population). Globally, life expectancy steadily improved between 1990 and 2019 for 18 of the 22 investigated causes. Decomposition of global and regional life expectancy showed the positive effect that reductions in deaths from enteric infections, lower respiratory infections, stroke, and neonatal deaths, among others have contributed to improved survival over the study period. However, a net reduction of 1¡6 years occurred in global life expectancy between 2019 and 2021, primarily due to increased death rates from COVID-19 and other pandemic-related mortality. Life expectancy was highly variable between super-regions over the study period, with southeast Asia, east Asia, and Oceania gaining 8¡3 years (6¡7-9¡9) overall, while having the smallest reduction in life expectancy due to COVID-19 (0¡4 years). The largest reduction in life expectancy due to COVID-19 occurred in Latin America and the Caribbean (3¡6 years). Additionally, 53 of the 288 causes of death were highly concentrated in locations with less than 50% of the global population as of 2021, and these causes of death became progressively more concentrated since 1990, when only 44 causes showed this pattern. The concentration phenomenon is discussed heuristically with respect to enteric and lower respiratory infections, malaria, HIV/AIDS, neonatal disorders, tuberculosis, and measles. INTERPRETATION Long-standing gains in life expectancy and reductions in many of the leading causes of death have been disrupted by the COVID-19 pandemic, the adverse effects of which were spread unevenly among populations. Despite the pandemic, there has been continued progress in combatting several notable causes of death, leading to improved global life expectancy over the study period. Each of the seven GBD super-regions showed an overall improvement from 1990 and 2021, obscuring the negative effect in the years of the pandemic. Additionally, our findings regarding regional variation in causes of death driving increases in life expectancy hold clear policy utility. Analyses of shifting mortality trends reveal that several causes, once widespread globally, are now increasingly concentrated geographically. These changes in mortality concentration, alongside further investigation of changing risks, interventions, and relevant policy, present an important opportunity to deepen our understanding of mortality-reduction strategies. Examining patterns in mortality concentration might reveal areas where successful public health interventions have been implemented. Translating these successes to locations where certain causes of death remain entrenched can inform policies that work to improve life expectancy for people everywhere. FUNDING Bill & Melinda Gates Foundation
Study of Functional Vulnerability Status of Tehran Hospitals in Dealing With Natural Disasters
Introduction: At the time of disasters, hospitals are considered as one of the most important facilities which
should provide emergency services continuously. The purpose of this study was to determine the functional
vulnerability of Tehran hospitals in dealing with natural disasters.
Methods: This cross-sectional study was conducted in educational hospitals of Tehran University of Medical
Science (TUMS), in 2013. Of all 26 hospitals, 12 hospitals were selected through single-stage cluster sampling,
including six general (Shariati, Amiralam, Sina, Imam, Hazrat Rasoul, Baharlou) and six specialized (Bahrami,
Hazrat-e Aliasghar, Shahid rajaie, Roozbeh, Moheb yas, Children Medical Center) hospitals. Data were collected
using World Health Organization (WHO) checklist for functional indicators of safe hospitals, recommended for
countries with similar climates. Data were collected through interviews with members of hospital crisis
committees and direct observations. Data analysis was carried out using SPSS version 18 using descriptive
statistics and Fisher's exact test.
Results: Fifty percent of hospitals in the study, in terms of functional vulnerability status, were in satisfactory\ud
condition with low level of vulnerability, 41.7% were in the moderate level and 8.3% were in a non-satisfactory
condition with high levels of vulnerability. The results of Fisher's exact test showed that there wasn't a significant
correlation between functional vulnerability and hospitals lifespan (p=0.99) and type of specialty (p=0.99).
Conclusion: As this study, assesses hospitals' main weaknesses in terms of procedures, strategies, plans, human
resources, monitoring and evaluation, it is essential that each of these areas be reviewed by hospital managers
separately, in order to take significant actions to eliminate their weaknesses
Prevalence of sexually transmitted infections and associated risk behaviors in prisoners: A systematic review
Abstract Background and Aims Sexually transmitted infections (STIs) are one of the major health concerns globally. Generally, prisoners are at higher risks for STIs due to risk factors including; drugâuse, highârisk sexual behaviors, densely populated prisons, and poor living conditions. Therefore, we aimed to conduct a systematic review to evaluate the existing data on STI prevalence, and its associated risk factors among prisoners. Methods We conducted a systematic search of the literature using the keywords in Scopus, PubMed, Web of Science, and Google Scholar online databases. We selected all the relevant original studies in English through title/abstract and fullâtext screening process.â Results Based on the inclusion and exclusion criteria, we selected and reviewed 32 studies out of 96 identified papers. The most important STIâassociated risk factors among prisoners were drug use, low educational levels, and unsafe sex. The prevalence of STIs was heterogenous in selected studies and was reported as follows; Human Immunodeficiency Virus (HIV)Â (0%â14.5%), hepatitis B viruses (HBV) (0.04%â27.23%), hepatitis C viruses (HCV) (0.17%â49.7%), Syphilis (0.2%â22.1%), Chlamydia Trachomatis (CT) (1.02%â6.7%), Gonorrhea (0.6%â7.8%), and herpes simplex virusâ2 (HSVâ2) 22.4%. Conclusion This systematic review indicates that the prevalence of STIs (HIV, HBV, HCV, Syphilis, Chlamydia Trachomatis, Gonorrhea, and HSVâ2) among prisoners appears to be higher than the general population, with drug abuse, low educational levels, and unsafe sex as major risk factors
Trend of socio-demographic index and mortality estimates in Iran and its neighbors, 1990â2015; findings of the global burden of diseases 2015 study
BACKGROUND: The Global burden of disease and injuries study (GBD 2015) reports expected measures for years of life lost (YLL) based on socio-demographic index (SDI) of countries, as well as the observed measures. In this extended GBD 2015 report, we reviewed total and cause-specific deaths and YLL for Iran and all its neighboring countries between 1990 and 2015. METHODS: We extracted data from the GBD 2015 database. Observed YLL measures were calculated by multiplying the number of deaths by standard life expectancy at each age. SDI was a composite index, calculated based on income per capita, average years of schooling, and total fertility rate. The GBD world population was used for age standardization. RESULTS: All-ages crude death rate in Iran reduced from 665.6 per 100,000 population (95% uncertainty interval: 599.3â731.6) in 1990 to 487.2 (414.9â566.1) in 2015. The ratio of observed to expected YLL (O/E ratio) for all-causes ranged between 0.54 (Turkey) and 1.95 (Russia) in 2015. For Iran, the all-causes O/E ratio was less than 1 in all years (1990-2015), except 2003. However, cause-specific O/E ratio was more than 1 for some causes, including the top leading causes of YLL (ischemic heart disease, road injuries, and cerebrovascular disorders). Ischemic heart disease was the first or second cause of YLL in all comparator countries except Afghanistan. CONCLUSION: The leading YLL causes with high O/E ratios should be prioritized in public health efforts. In addition to research evidence, countries with low O/E ratios should be scrutinized to find feasible innovative interventions. Š 2017, Academy of Medical Sciences of I.R. Iran. All rights reserved